Targeted recombination was used to select mouse hepatitis virus isolates with stable and ef cient expression of the gene encoding the enhanced green uorescent protein (EGFP). The EGFP gene was inserted into the murine coronavirus genome in place of the nonessential gene 4. These viruses expressed the EGFP gene from an mRNA of slightly slower electrophoretic mobility than mRNA 4. EGFP protein was detected on a Western blot of infected cell lysates and EGFP activity ( uorescence) was visualized by microscopy in infected cells and in viral plaques. Expression of EGFP remained stable through at least six passages in tissue culture and during acute infection in the mouse central nervous system. These viruses replicated with similar kinetics and to similar nal extents as wild-type virus both in tissue culture and in the mouse central nervous system (CNS). They caused encephalitis and demyelination in animals as wild-type virus; however, they were somewhat attenuated in virulence. Isogenic EGFP-expressing viruses that differ only in the spike gene and express either the spike gene of the highly neurovirulent MHV-4 strain or the more weakly neurovirulent MHV-A59 strain were compared; the difference in virulence and patterns of spread of viral antigen re ected the differences between parental viruses expressing each of these spike genes. Thus, EGFP-expressing viruses will be useful in the studies of murine coronavirus pathogenesis in mice. Journal of NeuroVirology (2002) 8, 381-391.
Introduction
Murine coronavirus mouse hepatitis virus (MHV) infection of the mouse provides a model to study both acute and chronic virus-induced neurological disease as well as hepatitis. Intracranial or intranasal inoculation of susceptible mice with neurotropic strains of MHV results in a range of outcomes from acute encephalomyelitis to chronic demyelinating disease (Houtman and Fleming, 1996) . Two strains that differ markedly in their neurovirulence are MHV-4 and MHV-A59. Infection of C57BL/6 weanling mice with a low dose of the highly neurovirulent MHV-4 (a strain [JHM] isolate) produces a severe and fatal encephalitis, whereas much higher doses of MHV-A59, a mildly neurovirulent strain, are required to produce a mild encephalitis (Lavi et al, 1984 (Lavi et al, , 1990 Phillips et al, 1999) .
We have used targeted recombination to select viruses in which spike genes have either been exchanged between strains (Phillips et al, 1999; Das Sarma et al, 2000; Navas et al, 2001) or mutated at speci c sites within the gene. Infection of animals J Das Sarma et al with such viruses has allowed us to demonstrate that the spike gene plays a major role in the determining pathogenic outcome, including tissue tropism and virulence. An important aspect of these studies has been to observe the spread of viral antigen throughout the central nervous system (CNS) and quantify the numbers and locations of infected cells as a function of time after infection. This has been carried out by using viral speci c antibodies to detect antigen in tissue. Our goal here was to select recombinant viruses with ef cient and stable expression of a marker gene, enhanced green uorescent protein (EGFP), to facilitate the detection of spread of viruses within mice as well as to trace virus entry and spread in cell cultures.
Our approach was to replace a nonessential portion of the MHV genome with the EGFP gene. There are several MHV genes that have been demonstrated to be nonessential for replication in tissue culture. These include ORFs 2a (Schwarz et al, 1990) , ORFs 4a, 4b (or ORF4 in some strains) (Yokomori and Lai, 1991) , and ORF 5a (Yokomori and Lai, 1991) , which all encode small nonstructural proteins as well as the hemagglutinin-esteras e (HE) gene, which is expressed in some isolates of MHV-4, and is a pseudogene in A59 (Luytjes et al, 1988) . Recently, it has been shown that abrogation of expression of the JHM (MHV-4) ORF4 by interruption of the open reading frame does not decrease neurovirulence (Ontiveros et al, 2001) . Thus, gene 4 was chosen as a location to insert the EGFP gene. In a previous study (Fischer et al, 1997) , Masters and colleagues were able to replace gene 4 of MHV-A59 with the GFP gene; however, although mRNA encoding GFP was detected, the expression level of the protein was not suf ciently high to detect the activity by uorescent microscopy. We used a similar approach with modi cations designed to maximize expression levels. We used a modi ed version of the GFP gene, called enhanced green uorescent protein (EGFP), which has been optimized for brighter uorescence (Cormack et al, 1996) and in which codon utilization has been maximized for translation in eukaryotic cells (Haas et al, 1996) , and a modi ed EGFP donor plasmid, which results in selection of recombinant viruses with higher expression levels of the mRNA expressing EGFP.
We report here the expression of the EGFP gene from the position of gene 4 within recombinant viruses that express either the MHV-A59 or the MHV-4 spike gene but are otherwise isogenic. Expression of the EGFP gene is stable over multiple passages in vitro and at a high enough level to readily detect in cultured cells and in the CNS of infected animals. These viruses re ect the pathogenic phenotypes of the parental viruses lacking EGFP. Thus, the use of EGFP as a marker protein promises to be useful in studies of viral spread in cultured cells as well as spread and pathogenesis in the mouse central nervous system.
Results

Selection of recombinant murine coronavirus expressing the enhanced green uorescent protein
Our approach to selecting a recombinant MHV expressing the marker protein, GFP, was to replace the MHV nonstructural gene 4 with the EGFP gene. As described above, we chose this region of the genome because it had been previously demonstrated that expression of gene 4 is not essential for the replication of MHV in vitro (Yokomori and Lai, 1991) , nor is it essential for full neurovirulence of MHV-JHM (Ontiveros et al, 2001) . We introduced the EGFP gene into recombinant isogenic viruses differing only in the spike gene; these are S A59 R, a recombinant wildtype MHV-A59, and S 4 R, a virus with the MHV-4 spike in place of the A59 spike, with all other genes derived from MHV-A59. The EGFP-expressing viruses were selected as described in Materials and methods. Brie y, targeted recombination was carried out between synthetic capped RNAs transcribed from pMH54 EGFP and pMH54-S4 EGFP and the recipient virus fMHV, according to the scheme depicted in Figure 1 and Materials and methods. Viral plaques exhibiting green uorescence, derived from putative recombinants, were picked and plaque-puri ed twice more. Two plaque-puri ed viruses, derived from independent recombination events for each plasmid, were used for further characterization . Recombinant viruses with the A59 spike were named S A59 R EGFP-1 and S A59 R EGFP-2 and those with the MHV-4 spike were named S 4 R EGFP-1 and S 4 R EGFP-2 . Because the two viruses in each pair were identical in all ways we have examined, we will show the data, in most cases, for only one and refer to them as S A59 R EGFP and S 4 R EGFP . (We have shown previously that pairs of viruses selected this way share all in vitro and in vivo properties examined) (Leparc-Goffart et al, 1998; Phillips et al, 1999) . Similarly, parental recombinant viruses S A59 R16 (wild-type MHV-A59) and S 4 R22 (expressing the MHV-4 spike, but otherwise isogenic with S A59 R16) will be referred to as S A59 R and S 4 R, respectively.
To con rm the presence of the EGFP gene in the recombinant viruses, reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was performed (Figure 2) . A primer pair (IZJ5 and IZJ6; Table 1 ) were used to amplify fragments of 600 and 770 base pairs, respectively, from RNA extracted from cells infected with S A59 R EGFP , S 4 R EGFP , as well as parental S A59 R and S 4 R and wild-type MHV-A59 and MHV-4. As expected, the primers in the N gene ampli ed a fragment from the RNAs of all viruses, wild-type MHV-A59 and MHV-4, recombinant parental viruses S A59 R and S 4 R, as well as EGFP-expressing viruses. The EGFP gene-speci c primers ampli ed only from the two EGFP-expressing viruses S A59 R EGFP and S 4 R EGFP , con rming that the EGFP gene was indeed present in these genomes and was of the expected size.
The replication of S A59 R EGFP and S 4 R EGFP recombinant viruses were compared to parental viruses S A59 R and S 4 R, respectively, by carrying out one-step growth curves in L2 cells. As shown in Figure 3 , all viruses replicated ef ciently. S A59 R EGFP replicated with similar kinetics, and to a similar nal extent, as S A59 R. As previously observed, viruses expressing the spike gene of MHV-4 (S 4 R and S 4 R EGFP ) replicated to lower nal titers than viruses expressing the A59 spike protein (S A59 R and S A59 R EGFP ). S 4 R EGFP replicated to similar nal titer as parental S 4 R but displayed slower kinetics. EGFP-expressing viruses induced cell-to-cel l fusion as parental viruses (see below, Figure 6 ).
Expression of EGFP mRNA and protein by recombinant viruses in vitro
We examined the mRNA patterns from EGFPexpressing recombinant viruses by carrying out Northern blots of RNA extracted from cells infected . Although mRNAs 5 to 7 of all viruses were identical in size, mRNA 4 of EGFP-expressing viruses migrated more slowly than the corresponding mRNAs from wild-type viruses. Interestingly, the levels of mRNA 4 were consistently higher in recombinant viruses as compared with wild-type parental MHV-A59 (compare lanes 2, 3, and 4, Figure 4 ). Although mRNA 4 was barely detectable in RNA from MHV-A59-infected cells (lane 2), it was abundant in RNA from either S A59 Ror S A59 R EGFP -infected cells (lanes 3 and 4). This phenomenon was observed previously with recombinant MHV-4 viruses (Ontiveros et al, 2001) ; the increased synthesis of mRNA 4 in the recombinant viruses resulted from the three nucleotide changes that were made in pMH54 in order to create an SbfI (Sse8387I) restriction site downstream of the S gene (see Materials and methods). The reason for the transcriptional up-regulation caused by these substitutions is currently unclear, but is likely helpful in achieving the desired level of EGFP expression. We next investigated the level of EGFP protein expression using immunoblots ( Figure 5 ). Protein lysates from cells infected with parental and EGFPexpressing recombinant viruses (as well as mockinfected cells) were analyzed by polyacrylamide gel electrophoreses, blotted onto polyvinyldene uoride (PVDF) membranes and probed with anti-EGFP (MHV RNA 7 appears to be less abundant than expected. This is probably because the gel was loaded with samples containing enough RNA to assure visualization of the larger, less abundant viral RNAs; the large amount of 18S ribosomal RNA present in these samples limits the binding of viral RNA 7 to the blot.) serum (Molecular Probe, Engene, OR) and in parallel with a monoclonal antibody directed against viral nucleocapsid (N) protein (Materials and methods). As expected, the anti-N antibodies recognized a 50-kDa band in lysates from cells infected with all viruses. (As has been observed previously [Bond et al, 1979] , the N protein of wild-type MHV-4 [lane 5] has slightly slower mobility than that of MHV-A59 or the recombinants, which all have the MHV-A59 N gene.) The anti-GFP antiserum recognized a polypeptide migrating at about 31 kDa in lysates from cells infected with EGFP-expressing viruses. Although the calculated molecular mass for monomeric EGFP is 27 kDa, the observations of a slightly slower electrophoretic mobility and the presence of other less prominent bands have been reported previously (Fischer et al, 1997) .
In order to be useful as a marker for infected cells, it was important that EGFP was expressed at a high enough level to readily detect by microscopy. Thus we examined murine L2 cells infected with either S A59 R or S A59 R EGFP at 12 h post infection, by both phase contrast and uorescent microscopy ( Figure 6 ). Similar levels of syncytia were observed in cells infected with either virus. However, EGFP uorescence is observed within the syncytia of cells infected with S A59 R EGFP . The absence of uorescence in S A59 R infected cells shows the speci city of the uorescence for EGFP.
Pathogenesis of viruses expressing EGFP and either the A59 or MHV-4 spike genes
Although it has been shown that expression of gene 4 was not necessary for full neurovirulence of MHV-4, this was demonstrated by introducing mutations within the gene rather than replacing the gene and altering the size of the gene (Ontiveros et al, 2001 
Figure 7
Viral replication in the brains of animals following intracranial inoculation. C57BL/6 weanling mice were infected with 10,000 PFU of S A59 R (°) and two clones of EGFP-expressing virus S A59 R EGFP-1 (¥) and S A59 R EGFP-1 (N). Animals were sacri ced at the indicated times, and virus titers in the brains were determined by plaque assay. The data shown represent the means (and standard deviations) of the titers from ve animals. The difference in titers between S A59 R and either S A59 R EGFP-1 or S A59 R EGFP-2 were statistically different at days 1 and 5 post infection, using the Wilcoxon rank sum W test; P D :009 for each pair of viruses.
and S 4 R. Thus, relative levels of virulence of the A59 spike-and MHV-4 spike-expressing viruses were similar to the relative levels of the parental viruses.
In order for these EGFP-tagged viruses to be useful in studies of viral pathogenesis, we needed to verify that they replicated ef ciently in the CNS and caused a similar disease, acute encephalitis (and, in addition, hepatitis in the case of S A59 R EGFP ), as well as chronic demyelinating disease, as parental viruses. Thus, we carried out intracranial inoculations of two independently isolated, clones of S A59 R EGFP (S A59 R EGFP-1 and S A59 R EGFP-2 ) and S A59 R at 10 4 plaque-forming unit (PFU)/mouse and measured virus replication in the brains as a function of time after infection. The kinetics and the nal viral titers were similar, albeit slightly lower, for the EGFP-expressing viruses compared to wild-type virus; the peak of viral replication was at day 5 for all viruses, as observed previously ( Figure 7 ) (Phillips et al, 1999) . (The differences in titer observed between S A59 R and S A59 R EGFP-1 or S A59 R EGFP-2 were statistically signi cantly at days 1 and 5.) We carried out similar infections with S 4 R and S 4 R EGFP in which we titered virus from brains at 5 days post infection. Similar to the result obtained for S A59 R and S A59 R EGFP , S 4 R EGFP replicated to a titer approximately 10-fold less than S 4 R. We had learned from previous studies that the level of infectious virus is not necessarily a predictor of virulence (Phillips et al, 1999 ); thus we carried out further comparisons of spread of these viruses.
We had shown previously that S A59 R and S 4 R, isogenic viruses differing only in the spike gene, displayed similar regional localization of antigenpositive cells, but different numbers of infected cells (Phillips et al, 1999) ; thus, the high neurovirulence of S 4 R was associated with larger numbers of infected cells. In order to determine whether this difference in spread of viral antigen was also a property for the EGFP-expressing viruses derived from S A59 R and S 4 R, we compared the spread of S A59 R EGFP and S 4 R EGFP in the CNS. Frozen sagittal brain sections, from the same animals described above, were post xed and examined for EGFP uorescence by microscopy as described in Materials and methods. EGFP was detected in discrete foci in the same regions of the brain in mice infected by both EGFPexpressing viruses as reported previously for parental viruses S A59 R and S 4 R. (We examined at least three sections from two animals infected with each virus.) There were no detectable differences in the regional location of viral antigen expression in the brain (Phillips et al, 1999) . Areas of viral antigen-positive cells for both viruses included the olfactory bulbs, mid brain, cortex, subiculum, basal forebrain structures, and regions of the brainstem. Figure 8 shows an example of a portion of sagittal sections cut from the middle of the brains of animals infected with S A59 R EGFP and S 4 R EGFP at the peak of viral antigen expression, day 5. Despite the similarity in regional localization in the brain, S 4 R clearly exhibited a significantly larger number of viral antigen-positive cells. When quanti ed (as described in Materials and methods), the area expressing EGFP uorescence was 10-fold greater in the section from a S 4 R EGFP -infected mouse as compared to that from a S A59 R EGFP -infected mouse. Figure 8 also shows higher magni cation of one region from each section; this illustrates the intracellular localizatio n of the uorescence.
We demonstrated previously that, along with increased numbers of viral antigen-positive cells, the brains of S 4 R-infected animals also displayed higher levels of in ammatory response than brains from S A59 R-infected mice, while appearing in the same regions in which viral antigen was detected (Phillips et al, 1999) . Thus, we examined the inammation in the brains of the same animals, at day 5, described above for EGFP detection. Thus, Figure 8 Viral antigen distribution in the CNS of animals infected with EGFP-expressing viruses. C57BL/6 weanling mice were infected with 3000 PFU of S4 R EGFP (panels A and B) and S A59 R EGFP (panels C and D). Animals were sacri ced at day 5 post infection, and the brains were processed, sectioned, and observed for uorescence, all as described in Materials and methods. In panels A and C, the bar represents 2.5 mm; the sections are labeled to orient the section. ctx, cortex; mb, midbrain; hc, hippocampus. Panels C and D are enlargements of the boxed areas in panels A and C; the bar represents 0.25 mm.
additional sections from the same animals analyzed above for viral antigen, infected with 3000 PFU of S A59 R EGFP and S 4 R EGFP , were stained with hematoxylin and eosin (H&E) and analyzed by light microscopy. Brains of animals infected with S 4 R EGFP revealed moderate encephalitis at day 5, whereas those infected with S A59 R EGFP had mild encephalitis. The regions in which in ammation was observed were the same as those positive for viral antigen and similar to those previously observed for parental viruses (Phillips et al, 1999) .
Infection of 4-week-old mice with recombinant MHV-A59 (S A59 R) as well as wild-type MHV-A59 caused chronic spinal cord demyelination; the peak of demyelination was at about 30 days postinfection (Sutherland et al, 1997; Matthews et al, 2001 ). We measured demyelination in mice infected with S A59 R or S A59 R EGFP at 30 days. At dose of approximately 1 LD 50 (5 £ 10 4 PFU), nearly all mice (9 of 10) infected with S A59 R EGFP demonstrated demyelination, with an average of 40% of the quadrants involved. All of the S A59 R-infected animals (3 of 3) exhibited demyelination, with the average of 58% of the spinal cord quadrants involved. The levels of demyelination observed for S A59 R EGFP -infected mice are well within the wide range of values observed with S A59 R-infected mice.
We also assessed animals infected with EGFPexpressing viruses for viral replication in the liver and hepatitis. Animals infected with S A59 R EGFP demonstrated hepatitis as evidenced by viral antigen expression and in ammation in the livers and replication of virus in the liver. Surprisingly, hepatitis was also observed in animals infected with S 4 R EGFP . This is likely due to the very high levels of virus inoculated into animals compared to previous studies, as it was also observed in animals infected with parental S 4 R.
Expression of EGFP is stable during passage in vitro and in vivo
In order to assess the stability of the EGFP gene in the recombinant virus, we passed S A59 R EGFP serially at a multiplicity of infection (MOI) of approximately 1 PFU/cell in L2 cells and examined plaques for EGFP uorescence at each passage. Nearly all of the plaques were positive for EGFP expression during at least six serial in vitro passages. Virus was plaqued from brain and liver homogenates from animals infected with S A59 R EGFP or S 4 R EGFP sacri ced 5 days post infection. EGFP uorescence was observed in nearly all of the plaques recovered from the brain. Thus, EGFP activity was stable in recombinant viruses through at least six passages in vitro and it was maintained during infection of the CNS. Interestingly, plaques recovered from the liver were mixed, with the majority negative for EGFP uorescence.
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Discussion
We have selected and characterize d recombinant murine coronaviruses that express EGFP. This is the rst demonstration of stable and ef cient expression of a foreign gene from a murine coronavirus genome. We have been able to use EGFP activity to trace the spread of viral antigen both in vitro and in vivo; furthermore, viruses expressing EGFP and either the A59 or MHV-4 spike proteins re ect the properties of the parental viruses, demonstrating that EGFP-tagged viruses will be useful in pathogenesis studies.
Our approach to expressing EGFP from the MHV genome was to select recombinant viruses in which nonstructural gene 4 has been replaced with the EGFP gene. We used this strategy because gene 4 is not essential for replication in tissue culture (Yokomori and Lai, 1991) nor for wild-type levels of neurovirulence (Ontiveros et al, 2001) . Furthermore, Fischer et al (1997) had been able to introduce the GFP gene into gene 4 and observe transcription of an mRNA encoding GFP and to detect the protein by Western blot; however, this recombinant virus was not useful for studies of viral spread because the levels of GFP expression were not high enough to detect by uorescence microscopy. We were able to achieve a signi cantly higher level of expression than that observed by Fischer et al (1997) , enough to easily detect by uorescence microscopy, both in infected cells in culture and in mice. This increased activity was a result of two factors. First, we used a modi ed GFP gene, EGFP (Clontech catalogue 6085-1) that encodes a red-shifted variant of wild-type GFP and has been optimized for brighter uorescence (Cormack et al, 1996) and in which codon utilization has been maximized for translation in mammalian cells (Haas et al, 1996) . The second factor is an unexplained increase in transcription of mRNA 4 that occurs when recombinant viruses are selected using derivatives of plasmid pMH54 in which an SbfI site has been introduced (by silent mutations) into the region between the spike gene and gene 4 (Figure 1 ). This phenomenon, previously reported by Ontiveros et al (2001) , can be observed in the comparison of expression of mRNA 4 from wild-type viruses A59 and MHV-4 and all of the recombinant viruses whether or not they express EGFP (Figure 4) . We ampli ed and sequenced the 5 0 end of the mRNA4/EGFP from S A59 R EGFP . This consensus sequence contained the 5 0 MHV-A59 leader sequence, followed by the intergenic sequence between spike and gene 4, followed by the EGFP gene. This was consistent with transcription of one major mRNA in the region of mRNA 4; we did not detect additional mRNAs encoding the EGFP gene, as was reported in a previous study (Fischer et al, 1997) .
We investigated whether expression of the EGFP gene was stable over many passages of virus in vitro and also during replication in mice. This was of concern, as the EGFP-expressing viruses replicate slightly less ef ciently as parental viruses and show some attenuation in virulence in mice; we, thus, reasoned that replication in vitro and or in mice may select for virus in which the EGFP gene has been deleted. Nearly all the plaques examined over six passages of virus in tissue culture retain EGFP uorescence. Furthermore, nearly all plaques isolated from the brains of infected mice at 5 days post infection are still expressing EGFP. Thus, expression of the EGFP gene remains stable through in vitro passage and during acute infection in the murine CNS. Interestingly, the majority of plaques recovered from the liver during actue infection were negative for EGFP activity. A similar organ-speci c loss of a foreign sequence was reported by Slifka et al (2001) . In this study, insertion of a foreign sequence from lymphocytic choriomeningitis virus (LCMV) into a recombinant coxsackievirus resulted in a virus that frequently deleted the LCMV sequence after inoculation into animals; the foreign sequences were lost more frequently in virus isolated from the heart whereas viruses isolated from the pancreas were more likely to retain the LCMV sequence (Slifka et al, 2001) .
The EGFP-expressing MHV isolated did display somewhat attenuated phenotypes, compared to parental viruses in vivo. This is not due to the disruption of gene 4, as it has been demonstrated that inactivation of gene 4 expression by the introduction of three nucleotide substitutions does not reduce replication of MHV-JHM in vitro nor does it reduce neurovirulence (Ontiveros et al, 2001 ). Thus it is likely that insertion of the EGFP gene (which is longer than ORF 4) confers a disadvantage to the virus, possibly because the EGFP gene alters the local structure of the RNA, thereby causing a slight disadvantage in replication that results in reduction in pathogenesis. As shown in Figure 7 , there is a small but signi cant difference in replication of S A59 R EGFP , as compared with S A59 R, in the mouse CNS. It is also possible, but less likely, that expression of EGFP itself may attenuate the EGFP-expressing viruses.
We have tested the utility of EGFP-expressing viruses for in vivo studies by selecting EGFPexpressing viruses that are isogenic except for the spike gene. We know from past studies that otherwise isogenic viruses expressing either the MHV-4 or A59 spike genes differ greatly in their neurovirulence, with the MHV-4 spike-expressing viruses (S 4 R) displaying very high neurovirulence and an LD 50 approximately 1000-fold lower than the mildly neurotropic A59 spike-expressing viruses (S A59 R) (Phillips et al, 1999) . Thus, we compared such viruses tagged with EGFP in infection and spread of virus in the CNS. EGFP-expressing viruses, expressing either the MHV-4 or A59 spike proteins, replicate ef ciently in the CNS and induce encephalitis. At least in the case of S A59 R EGFP , demyelination was also detected. (We did not examine demyelination for S 4 R EGFP .) The spread of the EGFP-expressing viruses within the CNS was similar to that reported for the parental viruses. Encephalitis was focal, with similar regions of involvement as previously reported (Phillips et al, 1999) . The major difference in viral antigen in the CNS for both parental and EGFP-expressing viruses is in the number of antigen-positive cells.
A potential use for EGFP-expressing viruses is to use uorescence to follow virus spread over time without having to terminate infection by xation and detection of viral antigen by immuno uorescence. This will be of use in cultured cells to monitor viral entry and to observe spread of virus by time-lapse microscopy using living cells. We have recently begun to examine virus spread over time in primary neuronal cultures. In a recent study (Smith et al, 2000) , an EGFP-tagged pseudorabies virus was used to enable in vitro electrophysiologica l analysis of infected neurons labeled transynaptically in vivo, demonstrating a potential use in tracing CNS circuitry. This could potentially be used to monitor spread through the CNS for MHV tagged with EGFP. Also, the ability to isolate EGFP-expressing cells infected with MHV makes it feasible to use uorescence-activate d cell sorting to determine the cell types infected by MHV.
Materials and methods
Virus and cells FCWF cells and fMHV were obtained from Paul S. Masters (Albany, New York). fMHV is a recombinant MHV that contains the ectodomain of the S protein of feline infectious peritonitis virus, with the rest of the genes derived from MHV-A59 (Kuo et al, 2000) . Parental viruses are S A59 R16, recombinant MHV-A59, and S 4 R22, isogenic with S A59 R16 except that it contains the MHV-4 spike gene (Phillips et al, 1999) . These parental viruses will be referred to more simply as S A59 R and S 4 R, respectively. Viruses were propagated on either murine 17Cl-1 cells or feline FCWF cells, and plaque assays and puri cations were carried out on murine L2 cells. Cells were maintained on plastic tissue culture asks in Dulbecco's minimal essential medium (DMEM) with 10% fetal bovine serum (FBS).
Plasmids and PCR mutagenesis
The pMH54 plasmid (obtained from Paul S. Masters) comprises codon 28 of the hemagglutinin esterase (HE) pseudogene through to the 3 0 end of the MHV-A59 genome, including a poly(A) tail, as described by Kuo et al (2000) , used as transcription vector to generate RNA for targeted recombination as described previously (Phillips et al, 1999; Das Sarma et al, 2000) . In order to replace gene 4 with the EGFP gene, pMH54 was modi ed by the introduction of a SalI site 42 nucleotides downstream of the intergenic sequence for gene 4a and a NotI site 102 bp upstream of the stop codon for gene 4b, using the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA). (These are coding-silent nucleotide changes.) The coding sequence of EGFP was cleaved from the pEGFP-N1 vector (Clontech, Palo Alto, CA) using SalI and NotI and inserted in the place of the SalI/NotI fragment of pMH54. The resulting plasmid contains 760 bp of non-MHV sequence, including the 722-bp EGFP open reading frame, replacing the entire gene 4a and the rst 213 bp of gene 4b. Then, to insert the EGFP fragment into the original unmodi ed pMH54 plasmid, a 1450-bp fragment of the EGFP-containing pMH54 was cleaved with SbfI (after the stop codon of the spike gene) and EcoRV at the 3 0 end of ORF 5b, the E gene, and inserted it into the corresponding sites in pMH54; the nal plasmid was called pMH54 EGFP . Finally, the 1450-nucleotide SbfI/EcoRV fragment of this construct was sequenced (Sanger et al, 1977) . To construct a similar plasmid differing only in the spike gene (called pMH54-S4 EGFP ), the MHV-4 spike gene was cleaved with AvrII and SbfI from pGEM-S4 (Phillips et al, 1999) and inserted into pMH54 EGFP in place of the A59 spike gene. For RNA transcription, the designated pMH54-derived plasmids were linearized just 3 0 to the poly(A) tail by digestion with PacI. The EGFP gene/viral junctions were sequenced in both pMH54 EGFP and pMH54-S4 EGFP using the primers FIJ81, FIJ83, RIJ84, and RIJ86 (Table 1) and the Taq dye terminator procedure (Taq DyeDeoxy Terminator Cycle Sequencing Kit; Applied Biosystems, Foster City, CA).
Targeted RNA recombination Targeted RNA recombination was carried out between synthetic capped RNAs transcribed from pMH54 EGFP or pMH54-S4 EGFP , using a T7 polymerase transcription kit (Ambion, Austin, TX) and fMHV as a recipient virus. Recombinant viruses in which the murine coronavirus spike gene has replaced the feline coronavirus spike gene were selected by replication in murine 17Cl-1 cells (Phillips et al, 2001; Kuo et al, 2000) . Candidate recombinants were plaque puri ed two times, and viral stocks were grown on 17Cl-1 cells for further characterization . For each desired recombinant, at least two viruses derived from independent recombination events were characterized . The viruses with the A59 spike were called S A59 R EGFP and those with the MHV-4 spike were called S 4 R EGFP . Although each individual virus was given a number, such as S A59 R EGFP-1 or S 4 R EGFP-1 , they will be referred to here more simply as S A59 R EGFP or S 4 R EGFP .
Virus growth curves
Con uent monolayers of L2 cells (in DMEM with 10% FBS) were infected with each virus (1 PFU/cell) in triplicate and incubated for 1 h at 37 ± C. Following adsorption, the cells were washed with Tris-buffered saline three times and then fed with DMEM-10% FBS. At the times indicated, the cells were lysed by
